Rolatam Transfection Technologies Market (2023-2028)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global transfection technologies market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the transfection technologies market. The secondary sources used for this study include US Food and Drug Administration (FDA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Organisation for Economic Co-operation and Development (OECD), Latin American Society for Developmental Biology, International Society for Cell & Gene Therapy (ISCT), American Society of Gene & Cell Therapy (ASGCT), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), South African Medical Research Council (SAMRC), National Institute for Health and Care Research (NIHR), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), National Institutes of Health (NIH), European Commission, and European Pharmaceutical Review. Secondary sources include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements), business magazines, research journals, press releases, articles & blogs. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global transfection technologies market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, CROs, CDMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the transfection technologies market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

Top-down Approach

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.